The final results of the African American Study of Kidney Disease and Hypertension (AASK) have shown that the angiotensin-converting enzyme inhibitor ramipril was better than the beta blocker metoprolol or the dihydropyridine calcium channel blocker amlodipine... ...

请注册登录后继续浏览